Anne O’Connor
Impact in
-
- Cardiac Valve Diseases and Treatments
- Cardiovascular Function and Risk Factors
- Antiplatelet Therapy and Cardiovascular Diseases
Papers in
-
- Metabolomics and Mass Spectrometry Studies 3
- Sphingolipid Metabolism and Signaling 1
-
- Cardiac Valve Diseases and Treatments 1
- Cardiovascular Function and Risk Factors 1
- Co-authors
- Valerie B. O’Donnell (3 shared papers)Stuart M. Allen (3 shared papers)David A. Slatter (2 shared papers)Saranya Ravi (1 shared paper)Robert C. Murphy (1 shared paper)Maceler Aldrovandi (1 shared paper)Victor Darley‐Usmar (1 shared paper)Ivan S. Salgo (1 shared paper)
- Journals
- Cell Metabolism (1 paper)Circulation Cardiovascular Imaging (1 paper)JCI Insight (1 paper)Bioinformatics (1 paper)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Anne O’Connor
4 papers receiving 272 citations
Peers
Comparison fields: 5 of 46
- Cardiology and Cardiovascular Medicine 147
- Biochemistry 34
- Epidemiology 93
- Spectroscopy 38
- Internal Medicine 7
Countries citing papers authored by Anne O’Connor
This map shows the geographic impact of Anne O’Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne O’Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne O’Connor more than expected).
Fields of papers citing papers by Anne O’Connor
This network shows the impact of papers produced by Anne O’Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne O’Connor. The network helps show where Anne O’Connor may publish in the future.
Co-authors
The 25 scholars most cited alongside Anne O’Connor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 132 | |
| 2 | 2010 | 113 | |
| 3 | 2017 | 31 | |
| 4 | 2020 | 4 |
About Anne O’Connor
Anne O’Connor is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Epidemiology, Computational Theory and Mathematics and Radiology, Nuclear Medicine and Imaging, having authored 4 papers that have together received 280 indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (3 papers), Cardiac Imaging and Diagnostics (1 paper), Computational Drug Discovery Methods (1 paper), Sphingolipid Metabolism and Signaling (1 paper), Liver Disease Diagnosis and Treatment (1 paper), Cardiac Valve Diseases and Treatments (1 paper), Cardiovascular Function and Risk Factors (1 paper) and Lipid metabolism and biosynthesis (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (147 citations), Biochemistry (34 citations), Epidemiology (93 citations), Spectroscopy (38 citations) and Internal Medicine (7 citations). Anne O’Connor has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Valerie B. O’Donnell, Stuart M. Allen, David A. Slatter, Saranya Ravi, Robert C. Murphy, Maceler Aldrovandi, Victor Darley‐Usmar, Ivan S. Salgo, Scott Settlemier and Sonal Chandra. Their work appears in journals such as Cell Metabolism, Circulation Cardiovascular Imaging, JCI Insight and Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.